US FDA approves AstraZeneca’s non-small cell lung cancer treatment
Imfinzi gains expanded use, and AstraZeneca’s shares rise after a priority review for small cell lung cancer
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Imfinzi
Biliary tract cancer drug Durvalumab approval key opportunity for AstraZeneca in India: GlobalData
Imfinzi is the only immunotherapy-based combination treatment option in India that offers significantly improved survival rates in…
AstraZeneca drug Imfinzi fails as monotherapy for type of lung cancer
Imfinzi, in a phase-III trial called 'Pearl', failed in patients whose tumour cells express high levels of PD-L1, or in a subgroup…
China approves Imfinzi to treat small cell lung cancer
Only PD-1/PD-L1 immunotherapy to demonstrate both a significant survival benefit and improved response rate in combination with a…
EU approves AstraZeneca’s Imfinzi for treatment of extensive-stage small cell lung cancer
Imfinzi, in combination with etoposide and either carboplatin or cisplatin, is also approved in the US, Japan and several other…
AstraZeneca’s Imfinzi gets FDA priority review for small cell lung cancer
The company said the FDA accepted its supplemental application and granted priority review to Imfinzi for the treatment of…